文献速递骨质疏松与钙磷/甲状旁腺肥胖与代谢综合征

遗传预测的终生循环25(OH)D水平与血钙及肾结石风险相关

Genetically Predicted Lifelong Circulating 25(OH)D Levels are Associated With Serum Calcium Levels and Kidney Stone Risk.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

结果显示,遗传预测的1-SD较高25(OH)D水平与血钙升高相关(IVW beta 0.014;95%CI 0.010-0.018;P=7.64E-10),并与KSD风险增加相关(IVW OR 1.47;95%CI 1.22-1.77;P=5.49E-05;MVMR-Egger OR 1.36;95%CI 1.03-1.80;P=0.029);二次分析结果类似。

要点

  • 遗传预测的较高终生25(OH)D水平与血钙升高相关。
  • 遗传预测的较高25(OH)D水平与肾结石病风险增加相关。
  • 多变量孟德尔随机化中25(OH)D对KSD的效应部分衰减但仍显著。

核心结论

  • 研究支持遗传预测的较高终生循环25(OH)D水平与较高血钙水平和肾结石病风险相关。
  • 25(OH)D对KSD的效应在多变量孟德尔随机化中部分衰减但仍显著。

研究设计与样本

  • 采用孟德尔随机化研究设计。
  • 主分析采用随机效应逆方差加权(IVW)及7种附加敏感性分析,并进行引入血钙水平的多变量孟德尔随机化(MVMR)。

主要发现

  • 遗传预测的1-SD较高25(OH)D水平与血钙升高相关(IVW;beta 0.014;95%CI 0.010-0.018;P=7.64E-10)。
  • 遗传预测的较高循环25(OH)D水平与KSD风险增加相关,每1-SD的IVW OR为1.47(95%CI 1.22-1.77;P=5.49E-05),MVMR-Egger OR为1.36(95%CI 1.03-1.80;P=0.029)。
  • 二次分析中,单变量孟德尔随机化IVW显示25(OH)D与KSD风险增加相关(OR 1.71;95%CI 1.26-2.32;P=0.001),MVMR显示OR 1.43(95%CI 1.16-1.76;P<0.001)。
  • 多数敏感性分析结果与主分析和二次分析的主要结果一致。

临床怎么用

  • 内分泌科评估维生素D状态时,可关注遗传预测的终生较高25(OH)D水平可能与血钙升高及肾结石风险增加相关。
  • 对血钙偏高或肾结石风险人群,补充维生素D的决策需综合评估,避免仅依据25(OH)D水平盲目高剂量补充。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether lifelong higher circulating 25-hydroxyvitamin D [25(OH)D] levels increase serum calcium levels and kidney stone disease (KSD) risk. METHODS: Summary data for KSD were obtained from the UK biobank genome-wide association study (6536 cases and 388 508 controls). We acquired summary data for 25(OH)D from 120 618 Europeans and another large-scale analysis (443 734 Europeans) for primary and secondary analysis. Random-effect inverse-variance weighted (IVW) and 7 additional sensitivity analyses were applied. Next, multivariable Mendelian randomization (MVMR) was performed by introducing data for serum calcium levels. RESULTS: Genetic predisposition for a 1-SD higher 25(OH)D level was associated with increased serum calcium levels (IVW; beta, 0.014; 95% CI, 0.010-0.018; P = 7.64E-10). Genetically predicted higher circulating 25(OH)D levels were associated with increased the risk of KSD, with per 1-SD odds ratios (ORs) of 1.47 (95% CI, 1.22-1.77; P = 5.49E-05) and 1.36 (95% CI, 1.03-1.80; P = 0.029) using the IVW and MVMR-Egger methods, respectively. In secondary analysis, similar results were found: 25(OH)D was associated with an increased risk of KSD in univariate Mendelian randomization (IVW; OR 1.71; 95% CI, 1.26-2.32; P = 0.001) and MVMR (OR 1.43; 95% CI, 1.16-1.76; P < 0.001) analyses. Most sensitivity analyses were consistent with the primary results, both for the primary and secondary analyses. CONCLUSIONS: Our study supports that higher genetically predicted lifelong circulating 25(OH)D levels are associated with higher calcium levels and KSD risk. The effects of 25(OH)D on KSD were partially attenuated-but still significant-in MVMR.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jian Z, Huang Y, He Y, et al. Genetically Predicted Lifelong Circulating 25(OH)D Levels are Associated With Serum Calcium Levels and Kidney Stone Risk. J Clin Endocrinol Metab. 2022. PMID: 34669929. doi:10.1210/clinem/dgab758

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。